8-K: CID Holdco Faces Nasdaq Delisting Threat, Secures Executive Loans

CID Holdco, Inc. received multiple Nasdaq deficiency notices for failing to meet listing standards, while its executives provided $208,000 in subordinated loans.

Summary

• CID Holdco, Inc. (DAIC) received multiple deficiency notices from Nasdaq regarding its continued listing requirements.
• Notices include failure to maintain a minimum bid price of $1 per share, minimum Market Value of Listed Securities (MVLS) of $50,000,000, and minimum total assets and revenue of $50,000,000 each.
• An additional notice cited failure to maintain a minimum market value of publicly held shares (MVPHS) of $15,000,000.
• These notices do not have an immediate effect on the stock's listing on the Nasdaq Global Market.
• The company has 180 calendar days, until August 4, 2026, to regain compliance with the minimum bid price and MVLS requirements.
• The company has until August 10, 2026, to regain compliance with the MVPHS requirement.
• CEO Edmund Nabrotzky, CFO Charles Maddox, and CTO Vijayan Nambiar loaned the company an aggregate of $208,000.00.
• Executives may make additional loans up to an aggregate of $600,000.00 (including amounts already extended).
• These Executive Loans are unsecured, subordinated promissory notes, accruing interest at 7.5% per annum, with payments due quarterly on July 1, 2026, October 1, 2026, and a final payment by December 31, 2026.
• The Executive Loans are subordinated to the company's obligations under a Loan Agreement with J.J. Astor & Co.

Sentiment

Score: 2

Explanation: StockSavvy.ai views this as a highly negative development due to multiple Nasdaq delisting threats, indicating severe operational and financial challenges, despite a small executive loan providing temporary liquidity.

Positives

• Company executives provided $208,000 in loans, with the potential for up to $600,000, indicating management's commitment and providing short-term liquidity.

Negatives

• Received multiple Nasdaq deficiency notices for failing to meet minimum bid price ($1 per share), minimum Market Value of Listed Securities ($50,000,000), and minimum total assets and revenue ($50,000,000 each).
• Received an additional deficiency notice for failing to maintain a minimum market value of publicly held shares ($15,000,000).
• Failure to cure these deficiencies by the compliance dates could lead to delisting from Nasdaq.
• The executive loans are subordinated to other company obligations, indicating a higher risk for these specific lenders.

Risks

• Risk of delisting from The Nasdaq Stock Market LLC if the company fails to regain compliance with minimum bid price, MVLS, and MVPHS requirements by the respective compliance dates (August 4, 2026, and August 10, 2026).
• Uncertainty regarding the company's ability to cure the deficiencies and maintain its Nasdaq listing.
• Potential for the Staff to determine the company will not be able to cure the deficiency, leading to delisting without an additional compliance period.
• No assurance that an appeal of a delisting determination by Nasdaq to a panel would be successful.

Future Outlook

The company intends to actively monitor its common stock's bid price and evaluate available options to resolve the deficiencies and regain compliance with Nasdaq's minimum bid price, MVLS, and MVPHS requirements by the respective compliance dates.

Management Comments

• The Company intends to actively monitor the bid price of its common stock between now and the applicable Compliance Date and, as appropriate, plans to evaluate available options to resolve the deficiencies and regain compliance with the minimum bid price requirement, MVLS requirement and MVPHS requirement.

Industry Context

StockSavvy.ai notes that companies facing multiple Nasdaq deficiency notices, particularly related to bid price and market capitalization, often struggle with investor confidence and liquidity. Such situations can lead to a 'death spiral' if not addressed effectively, as delisting can severely limit access to capital markets and reduce stock visibility. The executive loans, while a sign of internal support, are a small amount relative to the market capitalization deficiencies, suggesting deeper financial challenges.

Comparison to Industry Standards

• CID Holdco's failure to meet Nasdaq's minimum bid price of $1.00 per share is a common indicator of severe underperformance, contrasting sharply with established companies that consistently trade well above this threshold.
• The inability to maintain a $50 million Market Value of Listed Securities (MVLS) and $15 million Market Value of Publicly Held Shares (MVPHS) places CID Holdco significantly below the average market capitalization of companies listed on major exchanges, which typically range from hundreds of millions to billions of dollars.
• The 7.5% interest rate on executive loans, while potentially below market rates for distressed companies, is still a cost that adds to the company's financial burden, unlike well-capitalized peers that can secure financing at much lower rates or fund operations from robust cash flows.

Related Party Transactions

• CEO Edmund Nabrotzky, CFO Charles Maddox, and CTO Vijayan Nambiar loaned the company an aggregate of $208,000.00, with potential for up to $600,000.00 in total.
• These Executive Loans are unsecured, subordinated promissory notes accruing interest at 7.5% per annum.

Stakeholder Impact

• Shareholders: Face significant risk of delisting, which could severely impair liquidity and valuation of their holdings. The stock price is already below $1, indicating substantial capital loss.
• Creditors: The executive loans are subordinated, meaning other creditors (like J.J. Astor & Co.) have priority, increasing risk for the executive lenders but potentially providing a buffer for senior creditors.
• Employees: Potential uncertainty regarding the company's future and its ability to maintain operations if delisting occurs or financial health deteriorates further.

Next Steps

• Actively monitor the bid price of common stock.
• Evaluate available options to resolve deficiencies and regain compliance with Nasdaq listing requirements.
• Potentially submit an application to transfer to the Nasdaq Capital Market if minimum bid price compliance is not met but other requirements are.
• Consider appealing any delisting determination to a hearings panel.

Key Dates

Recommendation

The company faces imminent delisting from Nasdaq due to multiple severe non-compliance issues, including a sub-$1 bid price and insufficient market capitalization. While executive loans provide minor, short-term liquidity, they are insufficient to address the fundamental issues. The risk of delisting and subsequent loss of liquidity and investor confidence is extremely high, making the stock a strong sell.

Keywords

Nasdaq delisting, deficiency notice, minimum bid price, market value of listed securities, MVLS, MVPHS, executive loans, related party transaction, corporate finance, CID Holdco, DAIC, 8-K filing